Related Experiment Videos
Systemic lupus erythematosus and pheochromocytoma
1Division of Allergy, Immunology and Rheumatology, Chang Gung Memorial Hospital, Tao-Yuan, Taiwan, Republic of China.
The Journal of Rheumatology
|June 1, 1992
Summary
Pheochromocytoma, a rare adrenal tumor, can cause difficult-to-manage high blood pressure in patients with systemic lupus erythematosus (SLE). Surgical removal of the tumor improved hypertension without affecting SLE activity.
Area of Science:
- Endocrinology
- Nephrology
- Rheumatology
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect multiple organ systems.
- Hypertension is a common comorbidity in SLE patients, often linked to kidney disease or medication side effects.
Observation:
- A 40-year-old Chinese woman with established SLE and pre-existing hypertension presented with labile blood pressure.
- The patient's hypertension became increasingly difficult to control despite standard management.
- Diagnostic workup revealed an incidental finding of pheochromocytoma.
Findings:
- Surgical resection of the pheochromocytoma led to significant improvement in the patient's blood pressure control.
- Systemic lupus erythematosus disease activity remained stable postoperatively, unaffected by the tumor removal.
- This case highlights pheochromocytoma as a potential, albeit rare, secondary cause of hypertension in SLE.
Implications:
- Pheochromocytoma should be considered in the differential diagnosis of refractory or labile hypertension in SLE patients.
- Early diagnosis and treatment of pheochromocytoma can effectively manage hypertension in this vulnerable population.
- Understanding this association may improve clinical management strategies for SLE patients with complex hypertension.